GlassScriptPhysician profile
German Luy
NPI 1427260132
$818.04
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $104 · 2021: $19.56 · 2022: $40.74.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.34 | 2019-2020 | |
| Fisher & Paykel Healthcare INC | $159.67 | 2019 | |
| Sunovion Pharmaceuticals INC. | $96.09 | 2019-2020 | |
| Glaxosmithkline, LLC. | $68.86 | 2019 | |
| Genzyme Corporation | $66.92 | 2019 | |
| Paratek Pharmaceuticals, INC. | $40.74 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.97 | 2019 | |
| Philips North America LLC | $28.93 | 2019-2020 | |
| Genentech USA, INC. | $28.81 | 2019 | |
| Pfizer INC. | $19.88 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $19.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.65 | 2019 | |
| Circassia INC. | $16.37 | 2019 | |
| Mylan Specialty L.P. | $12.71 | 2019 | |
| Advanced Respiratory, INC | $11.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw German Luy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.